MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Metagenomi, Inc. stock related to its IPO conducted in February 2024, following the termination of a collaboration agreement with Moderna, which allegedly caused investor damages [1][5]. Group 1: Lawsuit Details - The class action lawsuit pertains to Metagenomi's IPO, where 6.25 million shares were sold at $15 each [5]. - The lawsuit claims that Metagenomi misrepresented its business relationship with Moderna, which was terminated less than three months after the IPO [5]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Investors wishing to join the class action can do so by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must file a motion with the court by November 25, 2024, to represent other class members [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements since 2013 [4].